General Information

Rps Biologiques Inc.


Address 59 Crestwood Drive Suite 100
Charlottetown, C1A 3H4
Canada
Address type Registered Office Address
Address province Prince Edward Island
Corporation ID 9232885
Business number 808567390
Status Active
ACT Canada Business Corporations Act
Anniversary date 03/25/2015
Last annual filing 2026
Data verified 10/31/2026

Description

Rps Biologiques Inc. is an active company which was registered under Canada Business Corporations Act with a corporation no 9232885 (business no 808567390). The incorporation was performed on 2015-03-25. The company is located in Charlottetown at 59 Crestwood Drive, Suite 100, C1A 3H4 in Prince Edward Island administrative division. As far as we established, the most recent annual meeting took place on 2017-04-04.
Other corporations nearby are: Found Network Inc., 8238367 Canada Inc., Merdock Group Inc., Orange Door Engineering Inc., Global Food Technologies Inc..

Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).

Company names

Name Effective date Type Current
RPS BIOLOGIQUES INC. 03/25/2015 Corporate Name true

Directors

Dr. Subrata Chowdhury
,
Ranjana Banerjee
,
J. Weston MacAleer
,

last updated: 2026-10-30

Government Grants and Contributions

18 federal grants and contributions between 2018 and 2026 with a total value of $808,355. The 10 most recent agreements are listed below.

Start dateDepartment and programValue
06/15/2026 National Research Council Canada
Industrial Research Assistance Program – Youth Employment Program (contribution)
Youth
Technical and manufacturing work related to firm's primary business of natural health products for veterinary and human use.
$30,000
07/15/2025 National Research Council Canada
Industrial Research Assistance Program (contribution)
IP Assist: Intellectual Property Strategy Engagement
The project will support development of intellectual property capacity within the firm.
$10,010
06/02/2025 National Research Council Canada
Industrial Research Assistance Program (contribution)
ICAP 2025 – International Co-Innovation Action Plan
The Firm produces Natural Products for fish health company. The Firm is looking to identify co-innovation partners who are experienced in the filed for the development of such products with field trials and have access to the majority of the Hatcheries, that are interested in collaborating with...
$50,000
05/19/2025 National Research Council Canada
Industrial Research Assistance Program (contribution)
Study on The Effects of Saprotect/Puralyze Oral Treatment on Growth of Altantic Salmon and Shrimp.
There is continued threat of fungus/Sea lice to hatchery reared Atlantic salmon and in many cases the use of formalin is demonstrating some resistance or the dosage used is having negative impacts on the recirculating water system’s biofilters. PuraLyze/Supratect has an opportunity as a natural...
$62,814
11/15/2023 Atlantic Canada Opportunities Agency
REGI - Business Scale-up and Productivity (contribution)
225209
Purchase of equipment to support production growth.
$191,000
06/22/2022 Atlantic Canada Opportunities Agency
REGI - Strategic Growth Initiative (SGI) (contribution)
221628
Hire a Business Development and Marketing Manager to implement growth strategy
$0
06/22/2022 Atlantic Canada Opportunities Agency
REGI - Strategic Growth Initiative (SGI) (contribution)
221628
$50,000
10/26/2021 National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms (contribution)
Pilot Study to Assess if a novel DNA and/or RNAi ISA vaccine can be administered through oral route to fish and a safety study of a plant-based feed stabilizer in Atlantic Salmon (Salmo salar).
The work proposed will take an innovative approach to the control and prevention of ISAV infection using DNA/RNAi technology to prevent virus from causing infection by blocking their ability to survive on the host. We have developed a unique oral vaccination platform based on this technology which...
$41,560
06/28/2021 National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms (contribution)
ISAV Vaccine Pilot Study
Pilot Study To Assess Efficacy of a Novel DNA and RNAi Vaccine Against ISAV (Infectious Salmon Anemia virus) Infection in Atlantic Salmon (Salmo salar).
$50,000
12/28/2020 Atlantic Canada Opportunities Agency
REGI - Productivity and Business Skills (contribution)
217842
Hire a full-time Manager of Operations
$50,000

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date Type Section
03/25/2015 Incorporation

Company annual return

Meeting date Type of corporation Year of filing
04/04/2017 Non-distributing corporation with 50 or fewer shareholders 2017
05/02/2016 Non-distributing corporation with 50 or fewer shareholders 2016